Avalo Therapeutics (AVTX) Return on Capital Employed (QoQ) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Avalo Therapeutics | 317.29 Mn | 317.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,434.00 |
| Dec 31, 2025 | -1,121.00 |
| Sep 30, 2025 | -762.00 |
| Jun 30, 2025 | -1,252.00 |
| Mar 31, 2025 | 2,198.00 |
| Dec 31, 2024 | 8,895.00 |
| Sep 30, 2024 | 12,676.00 |
| Jun 30, 2024 | -30,975.00 |
| Mar 31, 2024 | 16,913.00 |
| Dec 31, 2023 | 427.00 |
| Sep 30, 2023 | 12,847.00 |
| Jun 30, 2023 | -4,643.00 |
| Mar 31, 2023 | 7,190.00 |
| Dec 31, 2022 | -483.00 |
| Sep 30, 2022 | -7,478.00 |
| Jun 30, 2022 | -7,572.00 |
| Mar 31, 2022 | -1,523.00 |
| Dec 31, 2021 | 1,171.00 |
| Sep 30, 2021 | 5,125.00 |
| Jun 30, 2021 | 8,092.00 |
| Mar 31, 2021 | -6,387.00 |
| Dec 31, 2020 | -7,031.00 |
| Sep 30, 2020 | -750.00 |
| Jun 30, 2020 | 4,850.00 |
| Mar 31, 2020 | -12,487.00 |
| Dec 31, 2019 | -1,769.00 |
| Sep 30, 2019 | 3,985.00 |
| Jun 30, 2019 | 1,351.00 |
| Mar 31, 2019 | 37.00 |
| Dec 31, 2018 | 1,270.00 |
| Sep 30, 2018 | -11,354.00 |
| Jun 30, 2018 | -1,260.00 |
| Mar 31, 2018 | -2,626.00 |
| Dec 31, 2017 | -7,783.00 |
| Sep 30, 2017 | 49,512.00 |
| Jun 30, 2017 | 31,568.00 |
| Mar 31, 2017 | -19,807.00 |
| Dec 31, 2016 | -1,247.00 |
| Sep 30, 2016 | -29,938.00 |
| Jun 30, 2016 | -6,351.00 |
| Mar 31, 2016 | 4,026.00 |